Oxbryta Lawsuits

Oxbryta is a medication produced and distributed by Pfizer that treats sickle cell disease.

The drug was later recalled by the FDA and the recall states that the risks outweigh the benefits of this medication.

Pfizer voluntarily recalled all lots of the medication in September of 2024.

Oxbryta is an oral medication that is given by prescription only and available for treatment of sickle cell disease of 12 and older.

Sickle Cell Disease

Sickle cell disease is an inherited disease that affects hemoglobin, a protein necessary to carry oxygen in red blood cells.

When you have sickle cell disease the red blood cells are shaped like a C or sickle, these red blood cells are harder and sticky and can’t move as easily through the bloodstream.

This makes it harder to get oxygen to your organs and tissues.

Sickle cell disease can cause anemia, yellowing of the skin or eyes and mouth, a sudden drop in hemoglobin (this can be deadly if not treated immediately), and potentially a stroke.

Sickle cell disease is curable via a bone marrow transplant in some cases.

Another possible cure is gene therapy which is currently under investigation.

Bone marrow transplants are complex and have significant risks.

They are only considered for people with severe symptoms who have not responded to other treatments.

Treatments for Sickle Cell Disease

There are several treatments available for sickle cell disease including medications like Oxbryta.

There are several oral medications like this to treat the disease.

There are also other treatments like blood transfusions, stem cell transplants, gene therapy and bone marrow transplants.

It is also important to decrease the risk of infections by taking things like penicillin throughout one’s life or other medications that can prevent any infections.

Infections can lead to other health risks associated with sickle cell disease.

Oxbryta Recall

Oxbryta is a drug used to treat sickle cell disease and originally approved by the FDA, but was then recalled by the same FDA in September of 2024.

The drug was recalled due to serious side effects that outweighed the benefits of the drug.

The drug was recalled after post marketing studies showed that Oxbryta caused an increased risk of vaso-occlusive crisis.

This is a painful issue associated with sickle dell disease that happens when sickled red blood cells block the blood flow and oxygen delivery to tissues.

A few other issues were found with the use of Oxbryta, including a serious lung condition known as acute chest syndrome (ACS), kidney damage, stroke and even death.

These findings caused the FDA to react and recall the drug and stop any further prescriptions being given.

It is strongly suggested that you seek medical treatment by your provider and discuss other treatment options.

Speak with your medical provider about stopping the medication and starting a new treatment for sickle cell disease.

Also report any side effects that you may have suffered from taking Oxbryta.